Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa

Clinical Endocrinology

Volumn 56, Issue 3, 2002, Pages 391-396

  Stoving R K ^a   Andersen, M ^a   Flyvbjerg, A ^b   Frystyk, J ^b   Hangaard, J ^a   Vinten, J ^c   Koldkjaer O G ^d   Hagen, C ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Sonderborg Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; LEPTIN; PLACEBO; PYRIDOSTIGMINE; SOMATORELINACETAT; SOMATOSTATIN;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG POTENTIATION; FEEDING; FEMALE; FOOD INTAKE; HORMONE ACTION; HORMONE INHIBITION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOMATOSTATIN RELEASE; URINARY EXCRETION; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ANOREXIA NERVOSA; BODY MASS INDEX; CHOLINESTERASE INHIBITORS; DRUG SYNERGISM; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMUS; LEPTIN; PYRIDOSTIGMINE BROMIDE; WEIGHT GAIN;

EID: 0036229754     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01485.x     Document Type: Article

References (31)

1. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels
2. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation
3. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level
4. Weight regulation, leptin and growth hormone
5. Occult intracranial tumours masquerading as early onset anorexia nervosa
6. Central somatostatin: A re-examination of its effects on feeding
7. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia
8. Free insulin-like growth factors (IGF-I and IGF-II) in human serum
9. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients
10. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa
11. Contribution of CNS neuropep-tide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa
12. CSF somatostatin in anorexia nervosa and bulimia: Relationship to the hypothalamic-pituitary-adrenal cortical axis
13. Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosa
14. Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans
15. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine-and dopaminergic-stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers
16. Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications
17. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects
18. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels
19. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm
20. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro
21. Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders
22. Failure of glucose infusion to suppress the exaggerated GH response to GHRH in patients with anorexia nervosa
23. Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation
24. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat
25. Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis
26. Update on endocrine disturbances in anorexia nervosa
27. Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: Indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis
28. Diurnal variation of the serum leptin concentration in patients with anorexia nervosa
29. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor
30. The effects of growth hormone-releasing factor on food consumption in anorexia nervosa patients and normals